TN2013000503A1 - Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia - Google Patents

Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

Info

Publication number
TN2013000503A1
TN2013000503A1 TNP2013000503A TN2013000503A TN2013000503A1 TN 2013000503 A1 TN2013000503 A1 TN 2013000503A1 TN P2013000503 A TNP2013000503 A TN P2013000503A TN 2013000503 A TN2013000503 A TN 2013000503A TN 2013000503 A1 TN2013000503 A1 TN 2013000503A1
Authority
TN
Tunisia
Prior art keywords
treatment
piperazino
deuterated
schizophrenia
indanes
Prior art date
Application number
TNP2013000503A
Other languages
French (fr)
Inventor
Morten Jorgensen
Peter Hongaard Andersen
Klaus Gjervig Jensen
Mette Graulund Hvenegaard
Lassina Badolo
Mikkel Fog Jacobsen
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IB2012/001386 external-priority patent/WO2012176066A1/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of TN2013000503A1 publication Critical patent/TN2013000503A1/en

Links

Abstract

The present invention relates to deuterated 1-piperazino-3-phenyl-indanes and salts thereof with activity at dopamine receptors D1 and D2 as well as the 5HT2 receptors in the central nervous system, to medicaments comprising such compounds as active ingredients, to the use of such compounds in the treatment of diseases in the central nervous system, and to methods of treatment comprising administration of such compounds.
TNP2013000503A 2011-09-21 2013-12-03 Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia TN2013000503A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161537103P 2011-09-21 2011-09-21
PCT/IB2012/001386 WO2012176066A1 (en) 2011-06-20 2012-06-19 Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

Publications (1)

Publication Number Publication Date
TN2013000503A1 true TN2013000503A1 (en) 2015-03-30

Family

ID=54359615

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000503A TN2013000503A1 (en) 2011-09-21 2013-12-03 Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia

Country Status (1)

Country Link
TN (1) TN2013000503A1 (en)

Similar Documents

Publication Publication Date Title
MX2013014978A (en) Method of administration of 4-((1r,3s)-6-chloro-3-phenyl-indan-1- yl)-1,2,2-trimethyl-piperazine and the salts thereof in the treatment of schizophrenia.
IN2014DN09434A (en)
PH12015501404B1 (en) Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
MX2013014849A (en) Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia.
MX365939B (en) Nuclear transport modulators and uses thereof.
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
GB201111485D0 (en) Drug composition and its use in therapy
TN2014000001A1 (en) A new therapeutical composition containing apomorphine as active ingredient
MX344846B (en) Combination of active loaded granules with additional actives.
MX2014002395A (en) Novel rock kinase inhibitors.
GB201115977D0 (en) Neurodevelopmental disorders
TN2013000503A1 (en) Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
MY166773A (en) Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia
EP3064201A4 (en) Pharmaceutical composition for preventing and treating central nervous system diseases containing fluoxetine and vitamin c as active ingredients
IN2013MU01239A (en)
GB201111427D0 (en) Novel bisindolylmaleimides, pan-pkc inhibitors